High-value laboratory testing for hospitalized COVID-19 patients: a review

D Cihakova, MB Streiff, SP Menez, TK Chen… - Future …, 2021 - Taylor & Francis
We present here an evidence-based review of the utility, timing, and indications for
laboratory test use in the domains of inflammation, cardiology, hematology, nephrology and …

Biomarkers in the management of acute heart failure: state of the art and role in COVID‐19 era

A Aleksova, G Sinagra, AP Beltrami, A Pierri… - ESC Heart …, 2021 - Wiley Online Library
Acute heart failure (AHF) affects millions of people worldwide, and it is a potentially life‐
threatening condition for which the cardiologist is more often brought into play. It is crucial to …

[HTML][HTML] A review of the presentation and outcome of left ventricular thrombus in coronavirus disease 2019 infection

AM Philip, LJ George, KJ John, AA George… - Journal of clinical and …, 2021 - ncbi.nlm.nih.gov
Background: Cardiovascular complications of the coronavirus disease 2019 (COVID-19),
which is caused by the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) …

[HTML][HTML] Automated analysis of limited echocardiograms: Feasibility and relationship to outcomes in COVID-19

PA Pellikka, JB Strom, GM Pajares-Hurtado… - Frontiers in …, 2022 - frontiersin.org
Background As automated echocardiographic analysis is increasingly utilized, continued
evaluation within hospital settings is important to further understand its potential value. The …

[PDF][PDF] Presentations and outcomes of severe cardiac complications in COVID-19: Rhode Island experience

MD Arkadiy Finn, A Jindal… - Rhode Island Medical …, 2021 - researchgate.net
ABSTRACT Forty-one (41) patients admitted to Rhode Island hospitals with COVID-19 from
April to November 2020 were identified to have severe cardiac complications. Clinical …

Myocarditis and cardiac complications associated with COVID-19 and mRNA vaccination: a pragmatic narrative review to guide clinical practice

DJ Holland, PL Blazak, J Martin, J Broom… - Heart, Lung and …, 2022 - Elsevier
Coronavirus disease 2019 (COVID-19) caused by the SARS-CoV-2 virus is likely to remain
endemic globally despite widespread vaccination. There is increasing concern for …

Intracardiac Thrombus in COVID-19 Inpatients: A Nationwide Study of Incidence, Predictors, and Outcomes

A Agrawal, S Bajaj, U Bhagat, S Chandna… - …, 2024 - journals.sagepub.com
COronaVIrus Disease-2019 (COVID-19) is associated with a hypercoagulable state.
Intracardiac thrombosis is a potentially serious complication but has seldom been evaluated …

COVID-19 Associated Myocarditis: Prevalence, Pathophysiology, Diagnosis, and Management

J Yan, J Hong - Cardiology in Review, 2023 - journals.lww.com
Abstract Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2), has been a pandemic and affected public health …

[PDF][PDF] ALTERACIONES ECOCARDIOGRÁFICAS EN LESIÓN RENAL AGUDA EN PACIENTES HOSPITALIZADOS CON COVID-19 EN EL INSTITUTO NACIONAL DE …

JFP FÉLIX - 2021 - ru.dgb.unam.mx
ALTERACIONES ECOCARDIOGRÁFICAS EN LESIÓN RENAL AGUDA EN PACIENTES
HOSPITALIZADOS CON COVID-19 EN EL INSTITUTO NACIONAL DE CIEN Page 1 1 …

[PDF][PDF] Valvulopatías y Covid 19

NC Pulido, ALA Matabajoy… - Scientific and …, 2022 - medicaljournal.com.co
Heart valve diseases are pathologies of great importance in medical care, this article will
describe the pathophysiology, epidemiology and its association with Covid 19. During the …